In addition, basal expression levels of GLI1 and GLI2, which are downstream of Hh ligands, are higher in TNBC than in HR+ breast cancer, suggesting that this pathway may be especially relevant to this sub-type [53]. The gene discussed is GLI1; the disease is breast carcinoma.